I have two quick questions to Carol and Colleen.
What would be your opinion of Canadians when it comes to drug safety? Do you think they accept Durhane's proposal, which is, having checked for safety precautions as much as possible, letting products on even if they're not safe? Or do you think Canadians expect to see products on the market that are safe beyond a reasonable doubt, as much as it's possible given the science and our whole approach?
Secondly, with respect to progressive licensing, could you tell us what we've learned from Vioxx that raises concerns about progressive licensing and how it might lead to a focus on approval of already approved drugs for new medications?